Vaxcyte Inc (PCVX)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -86.57M | -71.19M | -87.15M | -113.03M | -196.68M | -114.47M | -152.98M | -139.92M |
Pre Tax Income | -78.05M | -60.46M | -68.34M | -92.66M | -180.8M | -95.02M | -128.7M | -103.13M |
Net Income | -78.05M | -60.46M | -68.34M | -92.66M | -180.8M | -95.02M | -128.7M | -103.13M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -85.69M | -70.54M | -84.68M | -111.39M | -196.67M | -114.35M | -152.59M | -139.63M |
EBITDA | -85.87M | -70.48M | -86.4M | -112.22M | -195.79M | -113.47M | -151.58M | -138.19M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 |
Operating Income | -89.58M | -103.67M | -232.26M | -468.04M |
Pre Tax Income | -89.22M | -100.08M | -223.49M | -402.27M |
Net Income | -89.22M | -100.08M | -223.49M | -402.27M |
Preferred Dividends | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -1.747 | -1.887 | -2.812 | -4.228 |
EBIT | -87.1M | -102.09M | -230.37M | -463.28M |
EBITDA | -88.18M | -101.87M | -229.66M | -464.89M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.